Responses
Clinical and epidemiological research
Extended report
Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
Compose a Response to This Article
Other responses
No responses have been published for this article.